Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence Feldmeyer

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
Journal of Dermatological Case Reports|December 22, 2011
Treatment of vulvar Paget disease with topical imiquimod: a case report and review of the literatureLaurence Feldmeyer, Katrin Kerl, Jivko Kamarashev, et al.
JAAD Case Reports|September 12, 2022
Localized aseptic neutrophilic dermatoses of the extremities triggered by stasis and tissue damage: Two case reports of an unrecognized condition misdiagnosed as bacterial cellulitisValentina A Imstepf, Christoph Schlapbach, Michael Benzaquen, et al.
Seminars in Immunopathology|June 7, 2021
Eosinophils in skin diseasesSusanne Radonjic-Hoesli, Marie-Charlotte Brüggen, Laurence Feldmeyer, et al.
International Journal of Molecular Sciences|July 9, 2022
The Fate of Epidermal Tight Junctions in the <i>stratum corneum</i>: Their Involvement in the Regulation of Desquamation and Phenotypic Expression of Certain Skin ConditionsMarek Haftek, Vinzenz Oji, Laurence Feldmeyer, et al.
Journal of the American Academy of Dermatology|November 18, 2017
Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single centerKeshavamurthy Vinay, Simone Cazzaniga, Kyle T Amber, et al.
Current Biology : CB|June 30, 2007
The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytesLaurence Feldmeyer, Martin Keller, Gisela Niklaus, et al.
Frontiers in Immunology|September 3, 2019
Effects of Omalizumab on FcεRI and IgE Expression in Lesional Skin of Bullous PemphigoidS Morteza Seyed Jafari, Karolina Gadaldi, Laurence Feldmeyer, et al.
Frontiers in Medicine|December 15, 2023
Case report: Area of focus of management of severe pityriasis rubra pilaris by dose optimization of adalimumab biosimilar in combination with acitretin and montelukastKristine Heidemeyer, S Morteza Seyed Jafari, Lena Farnina, et al.
Frontiers in Immunology|February 15, 2021
Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous PemphigoidS Morteza Seyed Jafari, Laurence Feldmeyer, Simon Bossart, et al.
Current Oncology (Toronto, Ont.)|November 10, 2022
The Feasibility of Immunocryosurgery in the Treatment of Non-Superficial, Facial Basal Cell Carcinoma That Relapsed after Standard Surgical Excision: An Experience Report from Two CentersGeorgios Gaitanis, Athanasia Zampeta, Panagiota Tsintzou, et al.
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
Journal of Dermatological Case Reports|December 22, 2011
Treatment of vulvar Paget disease with topical imiquimod: a case report and review of the literatureLaurence Feldmeyer, Katrin Kerl, Jivko Kamarashev, et al.
JAAD Case Reports|September 12, 2022
Localized aseptic neutrophilic dermatoses of the extremities triggered by stasis and tissue damage: Two case reports of an unrecognized condition misdiagnosed as bacterial cellulitisValentina A Imstepf, Christoph Schlapbach, Michael Benzaquen, et al.
Seminars in Immunopathology|June 7, 2021
Eosinophils in skin diseasesSusanne Radonjic-Hoesli, Marie-Charlotte Brüggen, Laurence Feldmeyer, et al.
International Journal of Molecular Sciences|July 9, 2022
The Fate of Epidermal Tight Junctions in the <i>stratum corneum</i>: Their Involvement in the Regulation of Desquamation and Phenotypic Expression of Certain Skin ConditionsMarek Haftek, Vinzenz Oji, Laurence Feldmeyer, et al.
Journal of the American Academy of Dermatology|November 18, 2017
Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single centerKeshavamurthy Vinay, Simone Cazzaniga, Kyle T Amber, et al.
Current Biology : CB|June 30, 2007
The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytesLaurence Feldmeyer, Martin Keller, Gisela Niklaus, et al.
Frontiers in Immunology|September 3, 2019
Effects of Omalizumab on FcεRI and IgE Expression in Lesional Skin of Bullous PemphigoidS Morteza Seyed Jafari, Karolina Gadaldi, Laurence Feldmeyer, et al.
Frontiers in Medicine|December 15, 2023
Case report: Area of focus of management of severe pityriasis rubra pilaris by dose optimization of adalimumab biosimilar in combination with acitretin and montelukastKristine Heidemeyer, S Morteza Seyed Jafari, Lena Farnina, et al.
Frontiers in Immunology|February 15, 2021
Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous PemphigoidS Morteza Seyed Jafari, Laurence Feldmeyer, Simon Bossart, et al.
Current Oncology (Toronto, Ont.)|November 10, 2022
The Feasibility of Immunocryosurgery in the Treatment of Non-Superficial, Facial Basal Cell Carcinoma That Relapsed after Standard Surgical Excision: An Experience Report from Two CentersGeorgios Gaitanis, Athanasia Zampeta, Panagiota Tsintzou, et al.
Pageof 10